Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Assembly Biosciences, Inc. (ASMB) had Return on Investments of -36.97% for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$6.84M |
|
$-9.61M |
|
-- |
|
$6.84M |
|
$17.80M |
|
$-10.96M |
|
$1.34M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-9.61M |
|
$-10.96M |
|
$-11.76M |
|
6.35M |
|
6.35M |
|
$-1.51 |
|
$-1.51 |
|
| Balance Sheet Financials | |
$98.21M |
|
$0.32M |
|
$2.05M |
|
$100.26M |
|
$41.63M |
|
-- |
|
$32.62M |
|
$74.26M |
|
$26.00M |
|
$26.00M |
|
$26.00M |
|
6.35M |
|
| Cash Flow Statement Financials | |
$-50.71M |
|
$46.87M |
|
$12.45M |
|
$19.84M |
|
$28.45M |
|
$8.61M |
|
$2.37M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-160.06% |
|
-160.06% |
|
-- |
|
-140.44% |
|
-140.44% |
|
$-50.74M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
-36.97% |
|
-36.97% |
|
-9.59% |
|
|
Return on Investments |
-36.97% |
$4.09 |
|
$-7.99 |
|
$-7.98 |
|